ABLE Human Motion
ABLE Human Motion is a Barcelona-based medical device company that designs, manufactures, and sells the CE-marked ABLE Exoskeleton — a 17 kg powered hip-knee robotic exoskeleton — to hospitals and rehabilitation centers in the European Union for clinical gait rehabilitation of patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases.
- Company typePrivate
- Founded2018
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
ABLE Human Motion firmographics
Firmographics- Name
- ABLE Human Motion
- Legal name
- ABLE Human Motion S.L.
- Website
- https://ablehumanmotion.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ABLE Human Motion is a Barcelona-based medical device company that designs, manufactures, and sells the CE-marked ABLE Exoskeleton — a 17 kg powered hip-knee robotic exoskeleton — to hospitals and rehabilitation centers in the European Union for clinical gait rehabilitation of patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases.
- Ownership category
- akta.pro rank
ABLE Human Motion industry classification
Industry- Product category
- Medical Robotic Exoskeletons
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Healthcare & Assistive Robotics (HDAAAIAC)
- akta.pro secondary industries
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)
Keywords
Where ABLE Human Motion is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
ABLE Human Motion business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Others
Revenue model
- Exoskeleton Device Sales: Sale of the ABLE Exoskeleton as a medical device to hospitals and rehabilitation centers in the European Union. The device is CE-marked under MDR regulation. Pricing is positioned as accessible and cost-effective compared to traditional exoskeletons (~200k EUR).
- Training and Implementation Services: Training programs provided to therapists with device purchase. Formation is necessary to operate the device, with a training program provided upon purchase.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Standard clinical exoskeleton for neurorehabilitation |
Go-to-market motion1 record
Distribution channels7 records
Marketing channels6 records
ABLE Human Motion product offering
Product offeringCore offering
ABLE Human Motion designs, manufactures, and commercializes a CE-marked lightweight (17 kg) hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation. The device assists patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases to stand, walk, turn, and sit during therapy sessions, and is sold to hospitals and rehabilitation centers across the European Union alongside the ABLE Care cloud-connected mobile application.
Product overview
ABLE Human Motion's product portfolio centers on the ABLE Exoskeleton — a CE-marked, hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation, designed and manufactured in Barcelona. The device is complemented by the ABLE Care mobile application, which provides a cloud-connected digital layer for session data management, real-time metrics, and personalized therapy tracking. A home-use version of the exoskeleton is in development, planned for a 2026 launch.
Differentiator
Problem solved
Functional benefit
Brands
- ABLE Care: Mobile application for personalized and data-driven rehabilitation therapy, syncing wirelessly with the ABLE Exoskeleton.
Products and services
- ABLE Exoskeleton Lightweight (17 kg), adjustable hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation, designed and manufactured in Barcelona. It assists patients with spinal cord injury (C5–L5), multiple sclerosis (EDSS up to 8.5), and neuromuscular diseases to stand up, walk, turn, and sit down. Features include quick donning in under 6 minutes, three step-initiation modes (manual button, center-of-mass weight shift, dynamic pelvic motion), active turning assistance, adjustable per-joint and per-gait-phase motor assistance, 2 batteries delivering 2–4 hours continuous use, and integration with the ABLE Care mobile application for data-driven therapy. CE-marked under EU MDR 2017/745 for use by hospitals and rehabilitation centers. Suitable for patients 150–190 cm tall and up to 100 kg.
Quantifiable outcome
- 500+ persons with neurological impairments walked 2,000,000+ steps with ABLE Exoskeleton
- +5 more outcomes
Companies that use ABLE Human Motion
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
ABLE Human Motion technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature8 records
ABLE Human Motion partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- BeMedicocoreOfficial distributor for BENELUX region (Belgium, Netherlands, Luxembourg). Handles commercialization of ABLE Exoskeleton in these markets. Contact: Mutsaardstraat 47, B-9550 Herzele, Belgium.
- Bayber Health S.L.coreOfficial distributor for Portugal. Commercializes ABLE Exoskeleton in the Portuguese market since September 2025. Contact: Calle Vilar de Donas 19, 28050 Madrid, Spain.
- PHYSIOMED Aparatura Medicala S.R.L.coreOfficial distributor for Romania. Handles commercialization of ABLE Exoskeleton in the Romanian market. Contact: Calea Turzii 189A, Cluj-Napoca, Romania.
- Skyfi Sp. z o. o.coreOfficial distributor for Poland. Handles commercialization of ABLE Exoskeleton in the Polish market. Contact: Ligocka Street 17A, 44-105 Gliwice, Poland.
- Roboticlever srlcoreOfficial distributor for Italy. Handles commercialization of ABLE Exoskeleton in the Italian market. Contact: Via Pietro di Pietramellara 12, 20158 Milano MI, Italy.
- Universitat Politècnica de Catalunya (UPC)coreAcademic partner from which ABLE Human Motion originated in October 2018. The Biomechanical Engineering Laboratory conducted research that led to the company's formation. Professor Josep M. Font (UPC) is a co-founder. UPC provides ongoing R&D collaboration.
- Institut GuttmanncoreLeading neurorehabilitation hospital in Barcelona that served as a clinical validation partner. Conducted clinical trials and provided feedback for product co-creation. Physiotherapist Mark Wright and rehabilitation physician Prof. José Estay have collaborated on clinical studies and testimonials.
- Hospital Asepeyo BarcelonacoreClinical partner that led the 2022 clinical trial in safety and functioning of the ABLE Exoskeleton (hip-knee version). Physiotherapist Mariona Tolrà contributed to product development and provided clinical feedback.
- Hospital Universitario de HeidelbergcoreLeading German neurorehabilitation center that collaborated on clinical trials for the ABLE Exoskeleton. Prof. Dr.-Ing. Rüdiger Rupp, Director of Experimental Neurorehabilitation Department, served as clinical advisor and provided testimonials.
- Hospital Sint Maartenskliniek (Netherlands)coreDutch hospital that conducted clinical research on sensory feedback in exoskeleton use with ABLE. Researchers Prof. Noël Keijsers and Eline Zwijgers studied the device's effectiveness and provided feedback for improvements. Collaboration began in July 2022.
- IISART (International Industrial Society in Advanced Rehabilitation Technology)minorMember of IISART, an association dedicated to advancing and promoting healthcare technology in rehabilitation. CEO Alfons Carnicero serves on the IISART Steering Committee. IISART represents developers, manufacturers, and marketers of medical devices in robotics and advanced healthcare technology.
- FENIN (Federación Española de Empresas de Tecnología Sanitaria)minorMember of the Spanish Federation of Medical Technology Companies, which aggregates manufacturers, importers, and distributors of technologies and health products in Spain.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
ABLE Human Motion competitors and assessment
Company assessmentDirect peers
- Ekso Bionics: US-based developer of EksoGT and other lower-extremity robotic exoskeletons for clinical neurorehabilitation and stroke/spinal cord injury gait training. Direct competitor in CE/FDA-regulated hospital exoskeletons targeting the same indications as ABLE.
- ReWalk Robotics: Israeli/US public company offering the ReWalk Personal and ReStore soft exoskeleton systems for SCI and stroke rehabilitation. Competes with ABLE in both clinical gait training and (eventually) home/ambulatory use of powered exoskeletons.
- Cyberdyne: Japanese developer of the HAL (Hybrid Assistive Limb) lower-extremity exoskeleton used in hospitals for neurorehabilitation. Competes with ABLE in clinical gait training for SCI, stroke, and neuromuscular diseases.
- Bionik Laboratories: Canadian public company developing the ARKE lower-body exoskeleton for clinical gait rehabilitation. Closely comparable niche peer in size, indication focus, and clinical-only go-to-market.
Broad incumbents
- Ottobock: Global German incumbent in prosthetics, orthotics, and rehabilitation technology with a broader portfolio including orthotic exoskeletal devices. Competes indirectly in rehab clinics via established distribution and wider product breadth.
- Parker Hannifin (Indego): US industrial conglomerate whose Indego lower-limb exoskeleton is sold for clinical and personal use. Comparable on product and customer segment, though Parker is a much larger diversified industrial player.
- Hocoma: Swiss-based global leader in robotic rehabilitation (Lokomat, Armeo, Erigo). Sells to the same hospital/rehab center buyer as ABLE but offers a much broader portfolio of robotic and sensor-based rehab devices.
Emerging players
- Fourier Intelligence: Chinese rehabilitation robotics company with lower-limb exoskeleton products (e.g., Fourier X1/X2) used in hospitals in Asia and expanding into Europe. Comparable on product category and clinical use case, with stronger manufacturing scale.
- Wearable Robotics: Italian developer of wearable exoskeletons for industrial and clinical applications. Comparable on underlying robotic exoskeleton technology and European clinical customer base, though with broader industrial focus.
- Rehab-Robotics (Hand of Hope): Hong Kong-based developer of robotic rehabilitation devices including upper-limb systems. Adjacent competitor in the robotic rehab device category, sharing the same clinical hospital buyer and regulatory pathway.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
ABLE Human Motion social profiles
Digital presenceABLE Human Motion compliance and trust
Trust signalCompliance2 records
ABLE Human Motion financial estimates
Financial estimateRevenue estimate
Valuation estimate
ABLE Human Motion leadership team
Management profileNumber of profiles
Profiles4 records
ABLE Human Motion funding detail
Funding detailFunding overview
Funding rounds7 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ABLE Human Motion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ABLE Human Motion
What does ABLE Human Motion do?
ABLE Human Motion designs, manufactures, and commercializes a CE-marked lightweight (17 kg) hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation. The device assists patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases to stand, walk, turn, and sit during therapy sessions, and is sold to hospitals and rehabilitation centers across the European Union alongside the ABLE Care cloud-connected mobile application.
Is ABLE Human Motion a public or private company?
ABLE Human Motion is a private company. It is classified as venture growth investor backed and is currently operating.
When was ABLE Human Motion founded?
ABLE Human Motion was founded in 2018. It employs 11 to 50 people.
Where is ABLE Human Motion based?
ABLE Human Motion is headquartered in Barcelona, Spain, in the Europe region.
How does ABLE Human Motion make money?
Two revenue lines are on record. Exoskeleton Device Sales are the primary driver. The others are training and Implementation Services.
Who are ABLE Human Motion's main competitors?
Direct peers on record are Ekso Bionics, ReWalk Robotics, Cyberdyne and Bionik Laboratories. Broad incumbents are Ottobock, Parker Hannifin (Indego) and Hocoma. Emerging players are Fourier Intelligence, Wearable Robotics and Rehab-Robotics (Hand of Hope).
Does ABLE Human Motion have an API?
No public API is recorded for ABLE Human Motion.
What industry is ABLE Human Motion in?
ABLE Human Motion's product category is Medical Robotic Exoskeletons. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3845.